Therefore, most obese patients with type 2 diabetes have hyperinsulinism, and higher insulin levels will reduce the level of IGFBP-1 (113), which makes IGF dissociate from IGFBP-1, and then act on IGF-R. The gene discussed is IGFBP1; the disease is hyperinsulinism.